Literature DB >> 21508113

In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects.

Edoardo Villani1, Silvia Beretta, Daniela Galimberti, Francesco Viola, Roberto Ratiglia.   

Abstract

PURPOSE: To investigate by laser scanning confocal microscopy (LSCM) the density of presumed epithelial, presumed goblet, and presumed inflammatory cells in the tarsal conjunctiva of healthy young and older subjects and in patients with Sjögren's syndrome (SS). To evaluate the interobserver variability and to compare the measured densities with known age-related and SS-related changes.
METHODS: The authors studied 24 eyes of 12 healthy young subjects (8 women, 4 men; average age, 26 years; age range, 21-30 years), 24 eyes of 12 healthy older subjects (10 women, 2 men; average age, 68 years; age range, 67-74 years), and 24 eyes of 12 patients with SS (10 women, 2 men; average age, 62 years; age range, 49-72 years). The inferior tarsal conjunctiva of each patient was examined in vivo by LSCM. The density of the three cell types was independently analyzed by two masked investigators.
RESULTS: The density of presumed epithelial, presumed goblet, and presumed inflammatory cells was significantly higher in SS patients than in both control groups (P < 0.001; Mann-Whitney U test). The densities for presumed goblet cells calculated by the two investigators were significantly different from one another (P < 0.01, Mann-Whitney U test) and were not correlated.
CONCLUSIONS: LSCM is a promising tool that should profoundly change the study of the ocular surface, but it requires accurate standardization before it is used in clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21508113     DOI: 10.1167/iovs.10-6215

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

Review 1.  In vivo confocal microscopy in dry eye disease and related conditions.

Authors:  Albert Alhatem; Bernardo Cavalcanti; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2012 Sep-Nov       Impact factor: 1.975

Review 2.  Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review.

Authors:  Cecilia Chao; Kathryn Richdale; Isabelle Jalbert; Kim Doung; Moneisha Gokhale
Journal:  Cont Lens Anterior Eye       Date:  2017-06-09       Impact factor: 3.077

3.  In vivo detection of clinically non-apparent ocular surface inflammation in patients with meibomian gland dysfunction-associated refractory dry eye symptoms: a pilot study.

Authors:  Y Qazi; A Kheirkhah; C Blackie; A Cruzat; M Trinidad; C Williams; D R Korb; P Hamrah
Journal:  Eye (Lond)       Date:  2015-06-19       Impact factor: 3.775

Review 4.  In vivo confocal microscopy of the ocular surface: from bench to bedside.

Authors:  Edoardo Villani; Christophe Baudouin; Nathan Efron; Pedram Hamrah; Takashi Kojima; Sanjay V Patel; Stephen C Pflugfelder; Andrey Zhivov; Murat Dogru
Journal:  Curr Eye Res       Date:  2013-11-11       Impact factor: 2.424

Review 5.  Sjögren syndrome: what and where are we looking for?

Authors:  Cintia S de Paiva; Eduardo Melani Rocha
Journal:  Curr Opin Ophthalmol       Date:  2015-11       Impact factor: 3.761

Review 6.  The ocular surface immune system through the eyes of aging.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2021-02-20       Impact factor: 5.033

7.  Observation of Conjunctiva-Associated Lymphoid Tissue With In Vivo Confocal Microscopy in Healthy Patients and Patients With Meibomian Gland Dysfunction.

Authors:  Yuting Liu; Yingbin Wang; Xin Jin; Nan Zhang; Yan Shi; Rui Zhu; Jingrao Wang; Yueyan Dong; Hong Zhang
Journal:  Cornea       Date:  2021-11-10       Impact factor: 3.152

8.  Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction.

Authors:  Yureeda Qazi; Ahmad Kheirkhah; Caroline Blackie; Monique Trinidad; Candice Williams; Andrea Cruzat; Donald R Korb; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.